PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.34 - 0.34
0.23 - 0.41
110.0K / 51.2K (Avg.)
-1.33 | -0.26
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-16.51%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-16.00%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-31.58%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-25.81%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-16.73%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-16.72%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-16.72%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
0.00%
Share reduction more than 1.5x 0464.HK's 0.02%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
No Data
No Data available this quarter, please select a different quarter.
-41.69%
Dividend reduction while 0464.HK stands at 5.09%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-100.83%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-98.73%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-0.74%
Negative 10Y revenue/share CAGR while 0464.HK stands at 47.13%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-0.74%
Negative 5Y CAGR while 0464.HK stands at 9.00%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
27.28%
3Y revenue/share CAGR above 1.5x 0464.HK's 5.52%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
-1641.60%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-1641.60%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-512.57%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-41.30%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-41.30%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-48.34%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
25.67%
3Y equity/share CAGR similar to 0464.HK's 25.96%. Walter Schloss sees both having parallel profitability or reinvestment over 3 years.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
6193.74%
AR growth of 6193.74% while 0464.HK is zero. Bruce Berkowitz wonders if the firm’s additional AR is warranted by strong revenue or potential risk.
28.40%
Inventory growth well above 0464.HK's 26.47%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-4.51%
Negative asset growth while 0464.HK invests at 2.46%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
0.85%
BV/share growth above 1.5x 0464.HK's 0.36%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
6.85%
Debt growth far above 0464.HK's 5.91%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
-17.92%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.